Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention Deficit Disorder with Hyperactivity | 248 | 2024 | 3724 | 16.780 |
Why?
|
Central Nervous System Stimulants | 98 | 2024 | 1168 | 13.260 |
Why?
|
Substance-Related Disorders | 111 | 2024 | 4422 | 9.750 |
Why?
|
Methylphenidate | 39 | 2024 | 480 | 4.920 |
Why?
|
Propylamines | 27 | 2012 | 161 | 3.320 |
Why?
|
Adrenergic Uptake Inhibitors | 20 | 2014 | 186 | 2.580 |
Why?
|
Conduct Disorder | 16 | 2023 | 245 | 2.450 |
Why?
|
Opioid-Related Disorders | 22 | 2024 | 2188 | 2.280 |
Why?
|
Bipolar Disorder | 46 | 2023 | 5130 | 1.820 |
Why?
|
Methamphetamine | 3 | 2024 | 167 | 1.690 |
Why?
|
Adolescent | 221 | 2024 | 89046 | 1.640 |
Why?
|
Psychotropic Drugs | 14 | 2015 | 881 | 1.630 |
Why?
|
Guanfacine | 7 | 2020 | 50 | 1.590 |
Why?
|
Comorbidity | 83 | 2024 | 10582 | 1.520 |
Why?
|
Executive Function | 7 | 2024 | 1396 | 1.490 |
Why?
|
Antidepressive Agents, Tricyclic | 21 | 2006 | 429 | 1.450 |
Why?
|
Alcoholism | 15 | 2021 | 1980 | 1.280 |
Why?
|
Child | 203 | 2024 | 80771 | 1.260 |
Why?
|
Amphetamines | 11 | 2008 | 142 | 1.250 |
Why?
|
Delayed-Action Preparations | 25 | 2021 | 965 | 1.240 |
Why?
|
Adolescent Psychiatry | 4 | 2024 | 165 | 1.190 |
Why?
|
Students | 8 | 2023 | 1744 | 1.190 |
Why?
|
Smoking | 19 | 2016 | 9081 | 1.070 |
Why?
|
Desipramine | 16 | 2005 | 183 | 1.060 |
Why?
|
Mental Disorders | 35 | 2022 | 6873 | 1.050 |
Why?
|
Child Psychiatry | 6 | 2024 | 230 | 1.000 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2016 | 92 | 0.970 |
Why?
|
Psychiatric Status Rating Scales | 52 | 2015 | 6023 | 0.930 |
Why?
|
Pyrrolidines | 4 | 2010 | 339 | 0.930 |
Why?
|
Humans | 360 | 2024 | 767040 | 0.930 |
Why?
|
Bupropion | 11 | 2006 | 303 | 0.930 |
Why?
|
Self Medication | 6 | 2024 | 115 | 0.920 |
Why?
|
Opiate Substitution Treatment | 7 | 2023 | 452 | 0.910 |
Why?
|
Cocaine | 3 | 2024 | 944 | 0.890 |
Why?
|
Prescription Drugs | 5 | 2024 | 635 | 0.890 |
Why?
|
Amphetamine-Related Disorders | 1 | 2024 | 80 | 0.870 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2024 | 627 | 0.790 |
Why?
|
Antidepressive Agents | 19 | 2014 | 2912 | 0.780 |
Why?
|
Female | 232 | 2024 | 396660 | 0.750 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 9 | 2023 | 305 | 0.730 |
Why?
|
Parents | 13 | 2024 | 3594 | 0.720 |
Why?
|
Analgesics, Opioid | 15 | 2024 | 3837 | 0.720 |
Why?
|
Male | 220 | 2024 | 364203 | 0.720 |
Why?
|
Antidepressive Agents, Second-Generation | 6 | 2005 | 491 | 0.710 |
Why?
|
Tic Disorders | 8 | 2024 | 140 | 0.710 |
Why?
|
Adolescent Behavior | 10 | 2024 | 1188 | 0.700 |
Why?
|
Mood Disorders | 10 | 2019 | 1129 | 0.690 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2021 | 155 | 0.690 |
Why?
|
Alcohol-Induced Disorders | 3 | 2011 | 27 | 0.680 |
Why?
|
Tourette Syndrome | 11 | 2017 | 400 | 0.680 |
Why?
|
Heart Rate | 13 | 2022 | 4209 | 0.670 |
Why?
|
Substance Abuse, Intravenous | 3 | 2019 | 530 | 0.670 |
Why?
|
Indans | 3 | 2006 | 92 | 0.660 |
Why?
|
Adult | 136 | 2024 | 223317 | 0.650 |
Why?
|
Clonidine | 11 | 2006 | 170 | 0.640 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2019 | 26 | 0.640 |
Why?
|
Young Adult | 44 | 2024 | 59980 | 0.640 |
Why?
|
Child of Impaired Parents | 6 | 2018 | 462 | 0.640 |
Why?
|
Buprenorphine | 7 | 2023 | 667 | 0.630 |
Why?
|
Family Health | 10 | 2014 | 1254 | 0.620 |
Why?
|
Inpatients | 4 | 2024 | 2563 | 0.620 |
Why?
|
Double-Blind Method | 35 | 2021 | 12451 | 0.620 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2015 | 286 | 0.620 |
Why?
|
Methadone | 8 | 2023 | 317 | 0.620 |
Why?
|
Phenobarbital | 1 | 2019 | 192 | 0.600 |
Why?
|
Drug Administration Schedule | 24 | 2017 | 4855 | 0.600 |
Why?
|
Dose-Response Relationship, Drug | 26 | 2017 | 10748 | 0.580 |
Why?
|
Postpartum Period | 3 | 2023 | 1198 | 0.580 |
Why?
|
Child Behavior | 3 | 2019 | 864 | 0.570 |
Why?
|
Benzodiazepines | 5 | 2024 | 1137 | 0.570 |
Why?
|
Marijuana Smoking | 2 | 2017 | 261 | 0.560 |
Why?
|
Psychopharmacology | 3 | 2024 | 146 | 0.560 |
Why?
|
Adrenergic alpha-Agonists | 4 | 2011 | 177 | 0.560 |
Why?
|
Nicotinic Agonists | 4 | 2010 | 265 | 0.560 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 16 | 2016 | 1987 | 0.560 |
Why?
|
Social Problems | 3 | 2022 | 107 | 0.550 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 188 | 0.540 |
Why?
|
Outpatients | 3 | 2023 | 1600 | 0.530 |
Why?
|
Social Environment | 2 | 2020 | 1012 | 0.530 |
Why?
|
Mothers | 5 | 2023 | 2209 | 0.510 |
Why?
|
Blood Pressure | 12 | 2022 | 8531 | 0.510 |
Why?
|
Family | 14 | 2019 | 3210 | 0.510 |
Why?
|
Patient Dropouts | 2 | 2017 | 411 | 0.500 |
Why?
|
Autistic Disorder | 2 | 2021 | 1239 | 0.490 |
Why?
|
Cannabinoids | 1 | 2017 | 174 | 0.490 |
Why?
|
Treatment Outcome | 57 | 2022 | 65295 | 0.480 |
Why?
|
Drug Therapy, Combination | 14 | 2016 | 6310 | 0.480 |
Why?
|
Anxiety Disorders | 17 | 2022 | 2745 | 0.480 |
Why?
|
Psychopathology | 5 | 2024 | 434 | 0.470 |
Why?
|
Nortriptyline | 7 | 2000 | 79 | 0.470 |
Why?
|
Prevalence | 26 | 2024 | 15851 | 0.470 |
Why?
|
Hypnotics and Sedatives | 3 | 2019 | 1193 | 0.470 |
Why?
|
Risk Factors | 58 | 2024 | 74886 | 0.460 |
Why?
|
Psychotherapy | 8 | 2024 | 1653 | 0.460 |
Why?
|
Pregnancy Complications | 5 | 2024 | 2971 | 0.460 |
Why?
|
Placebos | 13 | 2011 | 1660 | 0.460 |
Why?
|
Marijuana Abuse | 4 | 2022 | 409 | 0.450 |
Why?
|
Child Behavior Disorders | 10 | 2002 | 812 | 0.440 |
Why?
|
Depressive Disorder | 18 | 2007 | 3721 | 0.440 |
Why?
|
Dextroamphetamine | 3 | 2012 | 132 | 0.430 |
Why?
|
Homeless Youth | 2 | 2024 | 48 | 0.430 |
Why?
|
Age Factors | 36 | 2020 | 18401 | 0.430 |
Why?
|
Naltrexone | 4 | 2023 | 319 | 0.420 |
Why?
|
Case-Control Studies | 27 | 2020 | 22254 | 0.420 |
Why?
|
Diagnosis, Dual (Psychiatry) | 9 | 2014 | 300 | 0.420 |
Why?
|
Schools | 6 | 2023 | 1498 | 0.420 |
Why?
|
Isoxazoles | 2 | 2007 | 233 | 0.400 |
Why?
|
Nootropic Agents | 2 | 2020 | 159 | 0.400 |
Why?
|
Pyridines | 3 | 2010 | 2890 | 0.390 |
Why?
|
Cross-Over Studies | 13 | 2015 | 2105 | 0.390 |
Why?
|
Massachusetts | 15 | 2024 | 8890 | 0.390 |
Why?
|
Tobacco Use Disorder | 2 | 2008 | 708 | 0.390 |
Why?
|
Sertraline | 2 | 2006 | 210 | 0.390 |
Why?
|
Neuropsychological Tests | 19 | 2018 | 7121 | 0.380 |
Why?
|
Antipsychotic Agents | 8 | 2020 | 3078 | 0.380 |
Why?
|
Cholinesterase Inhibitors | 2 | 2006 | 242 | 0.370 |
Why?
|
Antimanic Agents | 5 | 2009 | 524 | 0.370 |
Why?
|
Piperidines | 3 | 2006 | 1667 | 0.370 |
Why?
|
Age of Onset | 12 | 2023 | 3344 | 0.370 |
Why?
|
Personality Assessment | 13 | 2012 | 646 | 0.360 |
Why?
|
Aggression | 5 | 2023 | 748 | 0.360 |
Why?
|
Alcohol-Related Disorders | 4 | 2019 | 243 | 0.360 |
Why?
|
Cognition | 10 | 2023 | 7059 | 0.350 |
Why?
|
Perioperative Care | 1 | 2018 | 1043 | 0.350 |
Why?
|
Universities | 5 | 2020 | 1004 | 0.350 |
Why?
|
Cholinergic Agents | 4 | 2004 | 97 | 0.340 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12536 | 0.340 |
Why?
|
Amphetamine | 4 | 2019 | 222 | 0.330 |
Why?
|
Pemoline | 4 | 2005 | 18 | 0.330 |
Why?
|
Fluoxetine | 3 | 2002 | 733 | 0.320 |
Why?
|
Obsessive-Compulsive Disorder | 5 | 2003 | 1495 | 0.320 |
Why?
|
Central Nervous System Depressants | 2 | 2011 | 163 | 0.320 |
Why?
|
Medication Adherence | 1 | 2021 | 2191 | 0.320 |
Why?
|
Motivation | 7 | 2020 | 2021 | 0.320 |
Why?
|
Delivery of Health Care | 4 | 2024 | 5363 | 0.320 |
Why?
|
Student Dropouts | 2 | 2018 | 27 | 0.310 |
Why?
|
Tachycardia | 3 | 2005 | 598 | 0.300 |
Why?
|
Prescriptions | 5 | 2024 | 388 | 0.300 |
Why?
|
Pilot Projects | 9 | 2024 | 8732 | 0.300 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2017 | 1399 | 0.290 |
Why?
|
Depressive Disorder, Major | 5 | 2022 | 4813 | 0.290 |
Why?
|
Norepinephrine | 2 | 2008 | 898 | 0.290 |
Why?
|
United States | 29 | 2024 | 72971 | 0.280 |
Why?
|
Attention | 6 | 2013 | 2413 | 0.280 |
Why?
|
Administration, Cutaneous | 4 | 2015 | 715 | 0.270 |
Why?
|
Siblings | 5 | 2016 | 828 | 0.270 |
Why?
|
Cannabis | 2 | 2023 | 447 | 0.260 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1672 | 0.250 |
Why?
|
Hostility | 1 | 2006 | 185 | 0.250 |
Why?
|
Antihypertensive Agents | 5 | 2006 | 2030 | 0.250 |
Why?
|
Self Report | 5 | 2024 | 3773 | 0.250 |
Why?
|
Exercise Test | 2 | 2012 | 2188 | 0.250 |
Why?
|
Psychometrics | 5 | 2020 | 3060 | 0.240 |
Why?
|
Synaptic Transmission | 2 | 2008 | 1175 | 0.240 |
Why?
|
Follow-Up Studies | 29 | 2018 | 39317 | 0.240 |
Why?
|
Hypertension | 4 | 2012 | 8615 | 0.240 |
Why?
|
Drug Prescriptions | 5 | 2024 | 1664 | 0.240 |
Why?
|
Death, Sudden, Cardiac | 3 | 2006 | 1567 | 0.240 |
Why?
|
Qualitative Research | 3 | 2024 | 3139 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3232 | 0.230 |
Why?
|
Antisocial Personality Disorder | 5 | 2023 | 224 | 0.230 |
Why?
|
Dietary Supplements | 1 | 2017 | 3446 | 0.230 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2023 | 109 | 0.230 |
Why?
|
Middle Aged | 44 | 2024 | 223233 | 0.230 |
Why?
|
Personality Development | 2 | 1995 | 241 | 0.220 |
Why?
|
Ethanol | 2 | 2011 | 1330 | 0.220 |
Why?
|
Retrospective Studies | 31 | 2024 | 81659 | 0.220 |
Why?
|
Clomipramine | 2 | 1995 | 50 | 0.220 |
Why?
|
Electrocardiography | 9 | 2009 | 6409 | 0.220 |
Why?
|
Pregnancy | 16 | 2024 | 30238 | 0.220 |
Why?
|
Ambulatory Care | 8 | 2021 | 2780 | 0.220 |
Why?
|
Interview, Psychological | 6 | 2016 | 810 | 0.220 |
Why?
|
Longitudinal Studies | 17 | 2024 | 14766 | 0.220 |
Why?
|
Dopamine | 3 | 2008 | 1581 | 0.210 |
Why?
|
Referral and Consultation | 6 | 2002 | 3618 | 0.210 |
Why?
|
Valproic Acid | 4 | 2009 | 444 | 0.210 |
Why?
|
Residential Treatment | 1 | 2024 | 112 | 0.210 |
Why?
|
Sex Factors | 15 | 2016 | 10622 | 0.200 |
Why?
|
Reference Values | 3 | 2019 | 4918 | 0.190 |
Why?
|
Legislation, Drug | 1 | 2024 | 216 | 0.190 |
Why?
|
Nicotine | 1 | 2007 | 680 | 0.190 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2006 | 597 | 0.190 |
Why?
|
Checklist | 2 | 2020 | 842 | 0.190 |
Why?
|
Social Work | 1 | 2023 | 158 | 0.190 |
Why?
|
Cognition Disorders | 8 | 2011 | 3968 | 0.190 |
Why?
|
Narcotic Antagonists | 1 | 2006 | 591 | 0.190 |
Why?
|
Tranquilizing Agents | 2 | 2018 | 59 | 0.190 |
Why?
|
Sex Distribution | 5 | 2008 | 2276 | 0.190 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2008 | 409 | 0.190 |
Why?
|
Alcohol Drinking | 2 | 2011 | 4045 | 0.180 |
Why?
|
Psychiatry | 2 | 2024 | 1715 | 0.180 |
Why?
|
Emotions | 1 | 2013 | 2760 | 0.180 |
Why?
|
Clinical Trials as Topic | 7 | 2014 | 8048 | 0.180 |
Why?
|
Cocaine-Related Disorders | 1 | 2024 | 458 | 0.180 |
Why?
|
Affective Symptoms | 2 | 2011 | 418 | 0.180 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26325 | 0.180 |
Why?
|
Time Factors | 11 | 2019 | 40154 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6513 | 0.170 |
Why?
|
Risk-Taking | 1 | 2006 | 1023 | 0.170 |
Why?
|
Cannabidiol | 1 | 2021 | 123 | 0.170 |
Why?
|
Educational Status | 2 | 2018 | 2511 | 0.170 |
Why?
|
Nausea | 3 | 2017 | 682 | 0.160 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2005 | 582 | 0.160 |
Why?
|
Substance Abuse Detection | 3 | 2007 | 301 | 0.160 |
Why?
|
Poison Control Centers | 1 | 2019 | 76 | 0.160 |
Why?
|
Severity of Illness Index | 17 | 2015 | 15925 | 0.160 |
Why?
|
Child, Preschool | 28 | 2023 | 42606 | 0.160 |
Why?
|
Heart | 1 | 2012 | 4429 | 0.160 |
Why?
|
Prospective Studies | 21 | 2024 | 54886 | 0.160 |
Why?
|
Enuresis | 1 | 1998 | 45 | 0.160 |
Why?
|
Mass Screening | 6 | 2021 | 5456 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1327 | 0.140 |
Why?
|
Parenting | 2 | 2023 | 708 | 0.140 |
Why?
|
Focus Groups | 1 | 2024 | 1460 | 0.140 |
Why?
|
Protriptyline | 1 | 1996 | 7 | 0.140 |
Why?
|
Social Class | 6 | 2016 | 2007 | 0.140 |
Why?
|
Anti-Anxiety Agents | 1 | 1999 | 405 | 0.140 |
Why?
|
Analysis of Variance | 4 | 2016 | 6215 | 0.140 |
Why?
|
Drug Tolerance | 1 | 2018 | 365 | 0.140 |
Why?
|
Diagnosis, Differential | 11 | 2014 | 12986 | 0.130 |
Why?
|
Drug Interactions | 7 | 2003 | 1419 | 0.130 |
Why?
|
Depression | 3 | 2018 | 8234 | 0.130 |
Why?
|
Drug Monitoring | 3 | 2010 | 963 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2024 | 807 | 0.130 |
Why?
|
Dwarfism | 1 | 1996 | 137 | 0.130 |
Why?
|
Maternal Exposure | 1 | 2023 | 1096 | 0.130 |
Why?
|
Statistics as Topic | 4 | 2016 | 2350 | 0.130 |
Why?
|
Administration, Oral | 4 | 2010 | 4026 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1791 | 0.120 |
Why?
|
Confidence Intervals | 3 | 2008 | 2920 | 0.120 |
Why?
|
Cyclohexanols | 1 | 1995 | 126 | 0.120 |
Why?
|
Transdermal Patch | 1 | 2015 | 51 | 0.120 |
Why?
|
Patient Satisfaction | 2 | 2024 | 3488 | 0.120 |
Why?
|
Intention | 1 | 2017 | 347 | 0.120 |
Why?
|
Drug Therapy | 1 | 2017 | 504 | 0.120 |
Why?
|
Databases as Topic | 2 | 2006 | 472 | 0.120 |
Why?
|
Vomiting | 1 | 2017 | 655 | 0.110 |
Why?
|
Child Abuse | 1 | 2023 | 1090 | 0.110 |
Why?
|
Health Surveys | 5 | 2020 | 4056 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2017 | 10393 | 0.110 |
Why?
|
Heroin Dependence | 1 | 2014 | 173 | 0.110 |
Why?
|
Central Nervous System Agents | 1 | 2014 | 71 | 0.110 |
Why?
|
Growth Disorders | 1 | 1998 | 635 | 0.110 |
Why?
|
Demography | 3 | 2008 | 1641 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1119 | 0.110 |
Why?
|
Logistic Models | 8 | 2023 | 13284 | 0.110 |
Why?
|
Histamine Agonists | 1 | 2012 | 13 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2024 | 5311 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 935 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7435 | 0.100 |
Why?
|
Psychotic Disorders | 3 | 2011 | 3275 | 0.100 |
Why?
|
Developmental Disabilities | 2 | 2010 | 1518 | 0.100 |
Why?
|
Carbamazepine | 2 | 2006 | 224 | 0.100 |
Why?
|
Social Behavior | 3 | 2006 | 1147 | 0.100 |
Why?
|
Incidence | 8 | 2020 | 21526 | 0.100 |
Why?
|
Odds Ratio | 5 | 2020 | 9660 | 0.090 |
Why?
|
Triazoles | 1 | 1997 | 903 | 0.090 |
Why?
|
Peer Group | 1 | 2017 | 702 | 0.090 |
Why?
|
Tricuspid Valve | 1 | 2014 | 419 | 0.090 |
Why?
|
School Health Services | 1 | 2015 | 388 | 0.090 |
Why?
|
Liver Function Tests | 2 | 2009 | 526 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2538 | 0.090 |
Why?
|
Infant | 7 | 2023 | 36485 | 0.090 |
Why?
|
Achievement | 5 | 2009 | 287 | 0.090 |
Why?
|
Remedial Teaching | 1 | 2010 | 16 | 0.090 |
Why?
|
Risk | 3 | 2016 | 9606 | 0.090 |
Why?
|
Long-Term Care | 3 | 2005 | 631 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2011 | 3431 | 0.090 |
Why?
|
Quinazolinones | 1 | 2012 | 219 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 436 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2429 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1413 | 0.090 |
Why?
|
Thioridazine | 1 | 1990 | 33 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1467 | 0.090 |
Why?
|
Body Height | 1 | 1996 | 1565 | 0.090 |
Why?
|
Anxiety | 4 | 2021 | 4670 | 0.090 |
Why?
|
Communication | 2 | 2019 | 3904 | 0.090 |
Why?
|
Metabolic Clearance Rate | 4 | 2012 | 361 | 0.080 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 240 | 0.080 |
Why?
|
Interviews as Topic | 4 | 2024 | 2741 | 0.080 |
Why?
|
Trichotillomania | 1 | 1992 | 178 | 0.080 |
Why?
|
Osmotic Pressure | 1 | 2010 | 136 | 0.080 |
Why?
|
Hemodynamics | 2 | 2001 | 4186 | 0.080 |
Why?
|
Parent-Child Relations | 2 | 2008 | 772 | 0.080 |
Why?
|
Corticosterone | 4 | 1985 | 301 | 0.080 |
Why?
|
Infant, Newborn | 7 | 2023 | 26396 | 0.080 |
Why?
|
Independent Living | 1 | 2013 | 584 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2005 | 8535 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 10 | 2016 | 18063 | 0.080 |
Why?
|
Cardiovascular System | 2 | 2006 | 839 | 0.080 |
Why?
|
Intelligence Tests | 2 | 2007 | 504 | 0.080 |
Why?
|
Panic Disorder | 2 | 2009 | 613 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3414 | 0.080 |
Why?
|
Patient Care Team | 3 | 2008 | 2516 | 0.080 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2008 | 30 | 0.080 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2008 | 69 | 0.080 |
Why?
|
Placebo Effect | 2 | 2009 | 516 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7236 | 0.070 |
Why?
|
Safety | 2 | 2006 | 1157 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1444 | 0.070 |
Why?
|
Dexamethasone | 3 | 1985 | 1963 | 0.070 |
Why?
|
Methionine Sulfoximine | 2 | 1984 | 12 | 0.070 |
Why?
|
Hydrocortisone | 3 | 1985 | 1840 | 0.070 |
Why?
|
Intelligence | 3 | 2011 | 925 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 326 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1029 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 251 | 0.070 |
Why?
|
Receptors, Dopamine D1 | 1 | 2008 | 276 | 0.070 |
Why?
|
Wechsler Scales | 3 | 2008 | 256 | 0.070 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2004 | 153 | 0.070 |
Why?
|
Mianserin | 1 | 2006 | 51 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2836 | 0.070 |
Why?
|
Psychological Tests | 4 | 2011 | 642 | 0.070 |
Why?
|
Epilepsy | 2 | 2017 | 3317 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 1531 | 0.070 |
Why?
|
Self Administration | 1 | 2008 | 386 | 0.070 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.060 |
Why?
|
Body Weight | 1 | 1996 | 4627 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2008 | 471 | 0.060 |
Why?
|
Nicotinic Antagonists | 1 | 2006 | 94 | 0.060 |
Why?
|
Primary Health Care | 2 | 2021 | 4746 | 0.060 |
Why?
|
Memory, Short-Term | 3 | 2008 | 1004 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15645 | 0.060 |
Why?
|
Tachycardia, Supraventricular | 1 | 2008 | 272 | 0.060 |
Why?
|
Self-Help Groups | 1 | 2006 | 194 | 0.060 |
Why?
|
Affect | 2 | 2003 | 1494 | 0.060 |
Why?
|
Mother-Child Relations | 1 | 2009 | 498 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2017 | 1107 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3467 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6489 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 606 | 0.060 |
Why?
|
Narcotics | 1 | 2007 | 332 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6813 | 0.060 |
Why?
|
Psychophysiologic Disorders | 1 | 2006 | 222 | 0.060 |
Why?
|
Receptors, Nicotinic | 1 | 2007 | 494 | 0.060 |
Why?
|
Cohort Studies | 5 | 2022 | 41718 | 0.050 |
Why?
|
Drug Evaluation | 1 | 2005 | 641 | 0.050 |
Why?
|
Sex Characteristics | 2 | 2005 | 2647 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 1197 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 277 | 0.050 |
Why?
|
Drugs, Essential | 1 | 2024 | 71 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1432 | 0.050 |
Why?
|
Pirenzepine | 1 | 2003 | 116 | 0.050 |
Why?
|
S-Adenosylhomocysteine | 5 | 1984 | 40 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2006 | 539 | 0.050 |
Why?
|
Temperament | 1 | 2005 | 301 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2003 | 411 | 0.050 |
Why?
|
Social Adjustment | 5 | 2011 | 634 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2011 | 4247 | 0.050 |
Why?
|
Homocysteine | 5 | 1984 | 637 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 646 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5101 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2008 | 1217 | 0.050 |
Why?
|
Psychology | 1 | 2024 | 353 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 415 | 0.050 |
Why?
|
Peripartum Period | 1 | 2023 | 137 | 0.050 |
Why?
|
Puberty | 1 | 2005 | 501 | 0.050 |
Why?
|
Pharmacogenetics | 1 | 2006 | 682 | 0.050 |
Why?
|
Drug Synergism | 1 | 2005 | 1759 | 0.050 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20169 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7848 | 0.050 |
Why?
|
Dizziness | 2 | 2006 | 269 | 0.050 |
Why?
|
Models, Psychological | 1 | 2005 | 823 | 0.050 |
Why?
|
Research Design | 4 | 2024 | 6210 | 0.050 |
Why?
|
Brain | 9 | 2010 | 27163 | 0.050 |
Why?
|
Causality | 1 | 2007 | 1253 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2850 | 0.050 |
Why?
|
Age Distribution | 2 | 2004 | 2870 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2009 | 4629 | 0.050 |
Why?
|
Risk Assessment | 4 | 2019 | 24299 | 0.050 |
Why?
|
Receptors, Presynaptic | 1 | 2000 | 15 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2003 | 609 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10815 | 0.040 |
Why?
|
Receptors, Catecholamine | 1 | 2000 | 6 | 0.040 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2005 | 497 | 0.040 |
Why?
|
Area Under Curve | 2 | 2003 | 1639 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 1990 | 2257 | 0.040 |
Why?
|
Automobile Driving | 1 | 2005 | 442 | 0.040 |
Why?
|
Regression Analysis | 4 | 2003 | 6331 | 0.040 |
Why?
|
Cholinergic Agonists | 1 | 1999 | 75 | 0.040 |
Why?
|
Anger | 1 | 2022 | 402 | 0.040 |
Why?
|
Prefrontal Cortex | 2 | 2008 | 2224 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2023 | 0.040 |
Why?
|
Appetite | 2 | 2017 | 247 | 0.040 |
Why?
|
Boston | 2 | 2024 | 9360 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 5042 | 0.040 |
Why?
|
Aged | 7 | 2023 | 171319 | 0.040 |
Why?
|
Smoking Cessation | 2 | 2008 | 2085 | 0.040 |
Why?
|
New York City | 1 | 2021 | 736 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 1999 | 291 | 0.040 |
Why?
|
Tandem Repeat Sequences | 1 | 1999 | 183 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2006 | 1921 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 489 | 0.040 |
Why?
|
Forecasting | 2 | 2005 | 2936 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2024 | 635 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2005 | 1078 | 0.040 |
Why?
|
Phenotype | 4 | 2008 | 16718 | 0.040 |
Why?
|
Disulfiram | 1 | 1998 | 63 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1574 | 0.040 |
Why?
|
Genetic Testing | 1 | 2011 | 3591 | 0.040 |
Why?
|
Social Stigma | 1 | 2024 | 788 | 0.040 |
Why?
|
Patient Compliance | 2 | 2005 | 2697 | 0.040 |
Why?
|
Risperidone | 1 | 1999 | 383 | 0.030 |
Why?
|
Attitude | 1 | 2022 | 769 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2024 | 2721 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2022 | 886 | 0.030 |
Why?
|
Medical Records | 3 | 1999 | 1409 | 0.030 |
Why?
|
Genome-Wide Association Study | 3 | 2011 | 12790 | 0.030 |
Why?
|
Growth | 1 | 1998 | 366 | 0.030 |
Why?
|
Sympatholytics | 1 | 1996 | 82 | 0.030 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2016 | 108 | 0.030 |
Why?
|
Psychological Techniques | 1 | 2016 | 48 | 0.030 |
Why?
|
Drug Users | 1 | 2018 | 134 | 0.030 |
Why?
|
Prognosis | 5 | 2008 | 29963 | 0.030 |
Why?
|
Nerve Net | 1 | 2008 | 2307 | 0.030 |
Why?
|
Live Birth | 1 | 2019 | 516 | 0.030 |
Why?
|
Clinical Protocols | 2 | 1998 | 1443 | 0.030 |
Why?
|
Self-Assessment | 1 | 1998 | 400 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2765 | 0.030 |
Why?
|
Environment | 1 | 2002 | 1120 | 0.030 |
Why?
|
Lithium | 1 | 1998 | 600 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2018 | 304 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1998 | 551 | 0.030 |
Why?
|
Verbal Learning | 2 | 2008 | 459 | 0.030 |
Why?
|
Probability | 2 | 1997 | 2476 | 0.030 |
Why?
|
Child Welfare | 1 | 1999 | 522 | 0.030 |
Why?
|
Hospitals, General | 1 | 2019 | 804 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1995 | 289 | 0.030 |
Why?
|
Nerve Tissue Proteins | 3 | 1984 | 4401 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2020 | 818 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3207 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 833 | 0.030 |
Why?
|
Pediatrics | 1 | 2009 | 3621 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 776 | 0.030 |
Why?
|
Nuclear Family | 2 | 2009 | 311 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1408 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1726 | 0.030 |
Why?
|
Internal-External Control | 1 | 1995 | 348 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2005 | 1945 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 353 | 0.030 |
Why?
|
Fear | 1 | 2022 | 1496 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3618 | 0.030 |
Why?
|
Linear Models | 4 | 2011 | 5875 | 0.030 |
Why?
|
Adenosine | 5 | 1984 | 812 | 0.030 |
Why?
|
Colic | 1 | 2012 | 43 | 0.030 |
Why?
|
Language | 1 | 2022 | 1550 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 1995 | 385 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3700 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4256 | 0.020 |
Why?
|
Semaphorin-3A | 1 | 2011 | 39 | 0.020 |
Why?
|
Biological Availability | 1 | 2012 | 387 | 0.020 |
Why?
|
Epidemics | 1 | 2017 | 516 | 0.020 |
Why?
|
Psychology, Social | 1 | 2011 | 52 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1002 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2302 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15424 | 0.020 |
Why?
|
Cardiac Complexes, Premature | 1 | 1990 | 63 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2011 | 316 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1993 | 913 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3883 | 0.020 |
Why?
|
S-Adenosylmethionine | 4 | 1984 | 219 | 0.020 |
Why?
|
Mental Health | 1 | 2024 | 3272 | 0.020 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.020 |
Why?
|
Child Development | 1 | 2000 | 2329 | 0.020 |
Why?
|
Family Relations | 1 | 2011 | 318 | 0.020 |
Why?
|
Liver | 2 | 2003 | 7578 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1096 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4526 | 0.020 |
Why?
|
Ammonia | 1 | 2009 | 244 | 0.020 |
Why?
|
Vital Signs | 1 | 2009 | 144 | 0.020 |
Why?
|
Methylation | 4 | 1984 | 1076 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2007 | 1886 | 0.020 |
Why?
|
Heart Block | 1 | 1990 | 391 | 0.020 |
Why?
|
Pre-Excitation Syndromes | 1 | 2008 | 27 | 0.020 |
Why?
|
Self Disclosure | 1 | 2009 | 248 | 0.020 |
Why?
|
Hospitals, University | 1 | 2009 | 570 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1101 | 0.020 |
Why?
|
Heart Ventricles | 2 | 1990 | 3837 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5519 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 792 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 392 | 0.020 |
Why?
|
Histamine | 3 | 1984 | 496 | 0.020 |
Why?
|
California | 1 | 2011 | 1439 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1605 | 0.020 |
Why?
|
Genotype | 3 | 2010 | 13035 | 0.020 |
Why?
|
Cause of Death | 1 | 1997 | 3717 | 0.020 |
Why?
|
Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2009 | 1623 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 784 | 0.020 |
Why?
|
Piperazines | 1 | 1997 | 2548 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
Problem Solving | 1 | 2008 | 442 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 1985 | 861 | 0.020 |
Why?
|
Hematocrit | 1 | 2007 | 622 | 0.020 |
Why?
|
Anorexia | 1 | 2006 | 153 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 434 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 1990 | 473 | 0.020 |
Why?
|
Blood Cells | 1 | 2007 | 309 | 0.020 |
Why?
|
Disease Progression | 4 | 2005 | 13646 | 0.010 |
Why?
|
Signal Transduction | 1 | 2008 | 23621 | 0.010 |
Why?
|
Diplopia | 1 | 2006 | 217 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36582 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2007 | 1002 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2010 | 16036 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1733 | 0.010 |
Why?
|
Reaction Time | 2 | 2008 | 2086 | 0.010 |
Why?
|
Methylhistamines | 1 | 1984 | 4 | 0.010 |
Why?
|
Hepatitis C | 1 | 2014 | 1594 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8068 | 0.010 |
Why?
|
Methionine | 2 | 1984 | 570 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1621 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8729 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6975 | 0.010 |
Why?
|
Adenosine Deaminase Inhibitors | 1 | 1982 | 9 | 0.010 |
Why?
|
Nucleoside Deaminases | 1 | 1982 | 58 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1983 | 365 | 0.010 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2003 | 108 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2005 | 996 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9362 | 0.010 |
Why?
|
Dysthymic Disorder | 1 | 2002 | 73 | 0.010 |
Why?
|
Movement Disorders | 1 | 2006 | 462 | 0.010 |
Why?
|
Biogenic Amines | 1 | 1981 | 53 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2005 | 1587 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 1985 | 555 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3266 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2598 | 0.010 |
Why?
|
Polyamines | 1 | 1981 | 132 | 0.010 |
Why?
|
Tics | 1 | 2001 | 76 | 0.010 |
Why?
|
Cross Reactions | 1 | 1983 | 828 | 0.010 |
Why?
|
Neurons | 1 | 2000 | 9517 | 0.010 |
Why?
|
Phospholipids | 2 | 1983 | 778 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2744 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1512 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1985 | 703 | 0.010 |
Why?
|
Genetic Variation | 2 | 2010 | 6611 | 0.010 |
Why?
|
Animals | 7 | 2007 | 168965 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2002 | 447 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2000 | 384 | 0.010 |
Why?
|
Dopamine Agents | 1 | 2000 | 186 | 0.010 |
Why?
|
Seizures | 2 | 1983 | 2996 | 0.010 |
Why?
|
Physician's Role | 1 | 2006 | 923 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2006 | 944 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1981 | 557 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1261 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12069 | 0.010 |
Why?
|
Epinephrine | 1 | 1981 | 782 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2002 | 1364 | 0.010 |
Why?
|
Pancreatitis | 1 | 2003 | 1087 | 0.010 |
Why?
|
Recurrence | 2 | 1999 | 8504 | 0.010 |
Why?
|
Lung | 1 | 2014 | 10076 | 0.010 |
Why?
|
Multigene Family | 1 | 1999 | 1081 | 0.010 |
Why?
|
Brain Stem | 1 | 1981 | 858 | 0.010 |
Why?
|
Memory | 1 | 2005 | 2192 | 0.010 |
Why?
|
Thyroid Hormone Resistance Syndrome | 1 | 1995 | 15 | 0.010 |
Why?
|
Education, Special | 1 | 1995 | 86 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2716 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2008 | 2787 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7868 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 1996 | 0.010 |
Why?
|
Marital Status | 1 | 1995 | 426 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1995 | 493 | 0.010 |
Why?
|
Genetic Markers | 1 | 1999 | 2602 | 0.010 |
Why?
|
Adenosylhomocysteinase | 2 | 1982 | 3 | 0.010 |
Why?
|
Thyrotropin | 1 | 1995 | 834 | 0.010 |
Why?
|
Thyroxine | 1 | 1995 | 666 | 0.010 |
Why?
|
Syndrome | 1 | 1998 | 3271 | 0.010 |
Why?
|
Hydrolases | 2 | 1982 | 146 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2513 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1982 | 4787 | 0.000 |
Why?
|
Alleles | 1 | 1999 | 6893 | 0.000 |
Why?
|
Survival Analysis | 1 | 1998 | 10092 | 0.000 |
Why?
|
Data Collection | 1 | 1995 | 3321 | 0.000 |
Why?
|
Sleep | 1 | 2001 | 4816 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1996 | 2662 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1982 | 10254 | 0.000 |
Why?
|
Quality of Life | 1 | 2005 | 13485 | 0.000 |
Why?
|
Mice | 4 | 1984 | 81912 | 0.000 |
Why?
|
Deoxyadenosines | 1 | 1982 | 27 | 0.000 |
Why?
|
Peromyscus | 1 | 1981 | 16 | 0.000 |
Why?
|
Putrescine | 1 | 1981 | 42 | 0.000 |
Why?
|
Spermidine | 1 | 1981 | 63 | 0.000 |
Why?
|
Histamine N-Methyltransferase | 1 | 1981 | 4 | 0.000 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 1981 | 18 | 0.000 |
Why?
|
Spermine | 1 | 1981 | 70 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1983 | 1765 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14672 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1983 | 951 | 0.000 |
Why?
|
Acoustic Stimulation | 1 | 1981 | 1253 | 0.000 |
Why?
|
Adenine | 1 | 1982 | 995 | 0.000 |
Why?
|
Cell Division | 1 | 1982 | 4473 | 0.000 |
Why?
|
Circadian Rhythm | 1 | 1981 | 2591 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1982 | 18989 | 0.000 |
Why?
|
Rats | 1 | 1981 | 23713 | 0.000 |
Why?
|